- Home
- HRMY vs SYBT Comparison
HRMY vs SYBT Comparison
Compare HRMY & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- SYBT
- Stock Information
- Founded
- HRMY 2017
- SYBT 1904
- Country
- HRMY United States
- SYBT United States
- Employees
- HRMY N/A
- SYBT N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- SYBT Major Banks
- Sector
- HRMY Health Care
- SYBT Finance
- Exchange
- HRMY Nasdaq
- SYBT Nasdaq
- Market Cap
- HRMY 1.8B
- SYBT 2.2B
- IPO Year
- HRMY 2020
- SYBT N/A
- Fundamental
- Price
- HRMY $34.43
- SYBT $78.08
- Analyst Decision
- HRMY Strong Buy
- SYBT Hold
- Analyst Count
- HRMY 9
- SYBT 3
- Target Price
- HRMY $54.44
- SYBT $80.33
- AVG Volume (30 Days)
- HRMY 594.8K
- SYBT 156.0K
- Earning Date
- HRMY 08-05-2025
- SYBT 07-23-2025
- Dividend Yield
- HRMY N/A
- SYBT 1.59%
- EPS Growth
- HRMY 13.13
- SYBT 16.29
- EPS
- HRMY 2.62
- SYBT 4.14
- Revenue
- HRMY $744,852,000.00
- SYBT $353,277,000.00
- Revenue This Year
- HRMY $20.33
- SYBT $14.39
- Revenue Next Year
- HRMY $17.67
- SYBT $5.04
- P/E Ratio
- HRMY $13.30
- SYBT $18.81
- Revenue Growth
- HRMY 20.62
- SYBT 8.97
- 52 Week Low
- HRMY $26.47
- SYBT $52.30
- 52 Week High
- HRMY $41.61
- SYBT $83.67
- Technical
- Relative Strength Index (RSI)
- HRMY 64.26
- SYBT 53.37
- Support Level
- HRMY $33.76
- SYBT $78.70
- Resistance Level
- HRMY $35.08
- SYBT $83.67
- Average True Range (ATR)
- HRMY 0.87
- SYBT 1.73
- MACD
- HRMY 0.34
- SYBT -0.23
- Stochastic Oscillator
- HRMY 92.43
- SYBT 34.13
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About SYBT Stock Yards Bancorp Inc.
Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.